FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Virginie Joulin

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Molecular Sequence Data

Anatomy

Co-author Network

Publications

TOP 3
A Girault; J-P Haelters; P-A Jaffrés; Virginie Joulin; M Potier-Cartereau; PHILIPPE BOUGNOUX; A Chantôme; Christophe Vandier
Targeting SKCa channels in cancer: potential new therapeutic approaches.
A Girault; J-P Haelters; Virginie Joulin; S Marionneau-Lambot; T Oullier; Michelle Pinault; M Potier-Cartereau; G Simon; PHILIPPE BOUGNOUX; A Chantome; B Corbel; H Couthon-Gourvès; P-A Jaffrès; Christophe Vandier
New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis.
Véronique Chajès; Virginie Joulin; Françoise Clavel-Chapelon
The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Virginie Joulin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: A Girault; J-P Haelters; P-A Jaffrés; Virginie Joulin; M Potier-Cartereau; PHILIPPE BOUGNOUX; A Chantôme; Christophe Vandier
Targeting SKCa channels in cancer: potential new therapeutic approaches.
Current medicinal chemistry 2012;19(5):697-713.
2011: A Girault; J-P Haelters; Virginie Joulin; S Marionneau-Lambot; T Oullier; Michelle Pinault; M Potier-Cartereau; G Simon; PHILIPPE BOUGNOUX; A Chantome; B Corbel; H Couthon-Gourvès; P-A Jaffrès; Christophe Vandier
New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis.
Current cancer drug targets 2011;11(9):1111-25.
2011: Véronique Chajès; Virginie Joulin; Françoise Clavel-Chapelon
The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk.
Current opinion in lipidology 2011;22(1):6-10.
2011: Marie Potier; A Chantome; Virginie Joulin; A Girault; Sébastien Roger; Pierre Besson; Marie-Lise Jourdan; J-Y LeGuennec; PHILIPPE BOUGNOUX; Christophe Vandier
The SK3/K(Ca)2.3 potassium channel is a new cellular target for edelfosine.
British journal of pharmacology 2011;162(2):464-79.
2010: Virginie Maillard; Kiyonori Kuriki; Benoît Lefebvre; Marie-Christine Boutron-Ruault; Gilbert M Lenoir; Virginie Joulin; Françoise Clavel-Chapelon; Véronique Chajès
Serum carotenoid, tocopherol and retinol concentrations and breast cancer risk in the E3N-EPIC study.
International journal of cancer. Journal international du cancer 2010;127(5):1188-96.
2010: Marie Potier; Truong An Tran; Aurelie Chantome; Alban Girault; Virginie Joulin; Philippe Bougnoux; Christophe Vandier; Fabrice Pierre
Altered SK3/KCa2.3-mediated migration in adenomatous polyposis coli (Apc) mutated mouse colon epithelial cells.
Biochemical and biophysical research communications 2010;397(1):42-7.
2009: Aurelie Chantome; Alban Girault; Marie Potier; Christine Collin; Pascal Vaudin; Jean-Christophe Pagès; Christophe Vandier; Virginie Joulin
KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility.
Experimental cell research 2009;315(20):3620-30.
2009: Anne C M Thiébaut; Maxime Rotival; Estelle Gauthier; Gilbert M Lenoir; Marie-Christine Boutron-Ruault; Virginie Joulin; Françoise Clavel-Chapelon; Véronique Chajès
Correlation between serum phospholipid fatty acids and dietary intakes assessed a few years earlier.
Nutrition and cancer 2009;61(4):500-9.
2008: Jean Bénard; Gilda Raguénez; Audrey Kauffmann; Alexander Valent; Hugues Ripoche; Virginie Joulin; Bastien Job; Gisèle Danglot; Sabrina Cantais; Thomas Robert; Marie-José Terrier-Lacombe; Agnès Chassevent; Serge Koscielny; Matthias Fischer; Frank Berthold; Marc Lipinski; Thomas Tursz; Philippe Dessen; Vladimir Lazar; Dominique Valteau-Couanet
MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S.
Molecular oncology 2008;2(3):261-71.
2008: Véronique Chajès; Anne C M Thiébaut; Maxime Rotival; Estelle Gauthier; Virginie Maillard; Marie-Christine Boutron-Ruault; Virginie Joulin; Gilbert M Lenoir; Françoise Clavel-Chapelon
Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study.
American journal of epidemiology 2008;167(11):1312-20.
2007: Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernhard RYFFEL; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Nature medicine 2007;13(9):1050-9.
2006: Marie Potier; Virginie Joulin; Sébastien Roger; Pierre Besson; Marie-Lise Jourdan; Jean-Yves Leguennec; Philippe Bougnoux; Christophe Vandier
Identification of SK3 channel as a new mediator of breast cancer cell migration.
Molecular cancer therapeutics 2006;5(11):2946-53.
2006: Véronique Chajès; Marie Cambot; Karen Moreau; Gilbert M Lenoir; Virginie Joulin
Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival.
Cancer research 2006;66(10):5287-94.
2005: Dan-Qing Lou; Thierry Molina; Myriam Bennoun; Arlette Porteu; Pascale Briand; Virginie Joulin; Mireille Vasseur-Cognet; Catherine Cavard
Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences.
Cancer letters 2005;229(1):107-14.
2005: Maureen T Travers; Marie Cambot; Helen T Kennedy; Gilbert M Lenoir; Michael Barber; Virginie Joulin
Asymmetric expression of transcripts derived from the shared promoter between the divergently oriented ACACA and TADA2L genes.
Genomics 2005;85(1):71-84.
2004: Olga M Sinilnikova; Sophie M Ginolhac; Clémence Magnard; Mélanie Léoné; Olga Anczukow; David Hughes; Karen Moreau; Deborah Thompson; Christine Coutanson; Janet Hall; Pascale Romestaing; Jean-Pierre Gérard; Valérie Bonadona; Christine Lasset; David E Goldgar; Virginie Joulin; Nicole Dalla Venezia; Gilbert M Lenoir
Acetyl-CoA carboxylase alpha gene and breast cancer susceptibility.
Carcinogenesis 2004;25(12):2417-24.
2002: J Guilherme Tralhao; Jean Roudier; Serban Morosan; Carlo Giannini; Hong Tu; Cyril Goulenok; Françoise Carnot; Flora Zavala; Virginie Joulin; Dina Kremsdorf; Christian Bréchot
Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(10):6991-6.
2002: Raphaëlle Gillet; Gisèle Grimber; Catherine Cavard; Myriam Bennoun; Alexandre Mignon; Pascale Briand; Virginie Joulin
Effect of Bcl-2 expression on hepatic preneoplasia in mice.
Cancer letters 2002;177(2):189-95.
2001: Raphaëlle Gillet; Catherine Cavard; Gisèle Grimber; Pascale Briand; Virginie Joulin
Hepatic expression of SV40 small-T antigen blocks the in vivo CD95-mediated apoptosis.
Biochemical and biophysical research communications 2001;284(2):369-76.
2000: Raphaëlle Gillet; Gisèle Grimber; Myriam Bennoun; C Caron de Fromentel; Pascale Briand; Virginie Joulin
The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
Oncogene 2000;19(31):3498-507.
1999: Alexandre Mignon; N Rouquet; Monique Fabre; S Martin; J C Pagès; J F Dhainaut; Axel Kahn; Pascale Briand; Virginie Joulin
LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.
American journal of respiratory and critical care medicine 1999;159(4 Pt 1):1308-15.
1998: Myriam Bennoun; Gisèle Grimber; Dominique Couton; A Seye; Thierry Molina; Pascale Briand; Virginie Joulin
The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice.
Oncogene 1998;17(10):1253-9.
1997: Alexandre Mignon; Jorge Cardoso; Virginie Joulin; Olivier Soubrane
[A drug for treating fulminant hepatitis?].
Gastroentérologie clinique et biologique 1997;21(8-9):581-3.
1996: N Rouquet; K Carlier; Pascale Briand; Joëlle Wiels; Virginie Joulin
Multiple pathways of Fas-induced apoptosis in primary culture of hepatocytes.
Biochemical and biophysical research communications 1996;229(1):27-35.
1996: N Rouquet; J C Pagès; Thierry Molina; Pascale Briand; Virginie Joulin
ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis.
Current biology : CB 1996;6(9):1192-5.
1996: S Le Ricousse; F Gouilleux; D Fortin; Virginie Joulin; H Richard-Foy
Glucocorticoid and progestin receptors are differently involved in the cooperation with a structural element of the mouse mammary tumor virus promoter.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(10):5072-7.
1996: N Rouquet; I Allemand; G Grimber; Thierry Molina; Pascale Briand; Virginie Joulin
Protection of hepatocytes from Fas-mediated apoptosis by a non-transforming SV40 T-antigen mutant.
Cell death and differentiation 1996;3(1):91-6.
1996: V Lacronique; Alexandre Mignon; Monique Fabre; Benoit Viollet; N Rouquet; Thierry Molina; Arlette Porteu; A Henrion; Didier Bouscary; Pascale Varlet; Virginie Joulin; Axel Kahn
Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice.
Nature medicine 1996;2(1):80-6.
1995: I Allemand; G Grimber; M Kornprobst; M Bennoun; Thierry Molina; Pascale Briand; Virginie Joulin
Compensatory apoptosis in response to SV40 large T antigen expression in the liver.
Oncogene 1995;11(12):2583-90.
1995: N Rouquet; I Allemand; Thierry Molina; M Bennoun; Pascale Briand; Virginie Joulin
Fas-dependent apoptosis is impaired by SV40 T-antigen in transgenic liver.
Oncogene 1995;11(6):1061-7.
1995: O Billet; G Grimber; M Levrero; K A Seye; Pascale Briand; Virginie Joulin
In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation.
Journal of virology 1995;69(9):5912-6.
1995: Virginie Joulin; H Richard-Foy
A new approach to isolate genomic control regions. Application to the GATA transcription factor family.
European journal of biochemistry / FEBS 1995;232(2):620-6.
1994: N Lecointe; O Bernard; K Naert; Virginie Joulin; C J Larsen; P H Romeo; D Mathieu-Mahul
GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
Oncogene 1994;9(9):2623-32.
1992: V Lemarchandel; Virginie Joulin; C Valentin; R Rosa; Frédéric Galactéros; J Rosa; M Cohen-Solal
Compound heterozygosity in a complete erythrocyte bisphosphoglycerate mutase deficiency.
Blood 1992;80(10):2643-9.
1991: Virginie Joulin; Dominique Bories; J F Eléouet; Marie-Claude Labastie; Stany Chrétien; M G Mattéi; Paul-Henri Roméo
A T-cell specific TCR delta DNA binding protein is a member of the human GATA family.
The EMBO journal 1991;10(7):1809-16.
1990: Yves Colin; Virginie Joulin; C Le Van Kim; Paul-Henri Roméo; J P Cartron
Characterization of a new erythroid/megakaryocyte-specific nuclear factor that binds the promoter of the housekeeping human glycophorin C gene.
The Journal of biological chemistry 1990;265(28):16729-32.
1990: J Castella-Escola; D M Ojcius; P LeBoulch; Virginie Joulin; Y Blouquit; Marie-Claude Garel; C Valentin; R Rosa; F Climent-Romeo; M Cohen-Solal
Isolation and characterization of the gene encoding the muscle-specific isozyme of human phosphoglycerate mutase.
Gene 1990;91(2):225-32.
1990: P H Romeo; M H Prandini; Virginie Joulin; V Mignotte; Michel Prenant; William Vainchenker; G Marguerie; Georges Uzan
Megakaryocytic and erythrocytic lineages share specific transcription factors.
Nature 1990;344(6265):447-9.
1989: Marie-Claude Garel; Virginie Joulin; P Le Boulch; M C Calvin; M O Préhu; Nicole Arous; R Longin; R Rosa; J Rosa; M Cohen-Solal
Human bisphosphoglycerate mutase. Expression in Escherichia coli and use of site-directed mutagenesis in the evaluation of the role of the carboxyl-terminal region in the enzymatic mechanism.
The Journal of biological chemistry 1989;264(32):18966-72.
1988: P Le Boulch; Virginie Joulin; Marie-Claude Garel; J Rosa; M Cohen-Solal
Molecular cloning and nucleotide sequence of murine 2,3-bisphosphoglycerate mutase cDNA.
Biochemical and biophysical research communications 1988;156(2):874-81.
1988: Virginie Joulin; Marie-Claude Garel; P Le Boulch; C Valentin; R Rosa; J Rosa; M Cohen-Solal
Isolation and characterization of the human 2,3-bisphosphoglycerate mutase gene.
The Journal of biological chemistry 1988;263(30):15785-90.
1988: E Roth; Virginie Joulin; S Miwa; A Yoshida; J Akatsuka; M Cohen-Solal; R Rosa
The use of enzymopathic human red cells in the study of malarial parasite glucose metabolism.
Blood 1988;71(5):1408-13.
1987: F Barichard; Virginie Joulin; I Henry; Marie-Claude Garel; C Valentin; R Rosa; M Cohen-Solal; Claudine Junien
Chromosomal assignment of the human 2,3-bisphosphoglycerate mutase gene (BPGM) to region 7q34----7q22.
Human genetics 1987;77(3):283-5.
1987: M Cohen-Solal; Virginie Joulin; P H Romeo; R Rosa; C Valentin; Marie-Claude Garel; J Rosa
Molecular cloning of the human 2,3-bisphosphoglycerate mutase cDNA and revised amino acid sequence.
Biomedica biochimica acta 1987;46(2-3):S126-30.
1986: Virginie Joulin; J Peduzzi; Paul-Henri Roméo; R Rosa; C Valentin; Anne Dubart; B Lapeyre; Y Blouquit; Marie-Claude Garel; M Goossens
Molecular cloning and sequencing of the human erythrocyte 2,3-bisphosphoglycerate mutase cDNA: revised amino acid sequence.
The EMBO journal 1986;5(9):2275-83.